In cancers such as renal, lung, ovarian, and glioblastoma, elevated GBP1 expression correlates with aggressive growth, metastasis, and resistance to therapies, marking it as an unfavorable prognostic factor [15,16,17,18,19,20,21]. The gene discussed is GBP1; the disease is glioblastoma.